Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 92751-92800 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04940013
Missed Period Pill Study
PHASE4
Active, not recruiting
100 participants
Started: Oct 25, 2021 · Completed: Sep 30, 2025
2 conditions
1 sponsor
1 location
NCT05002374
Vestibular Rehabilitation Incorporated With Optokinetic Stimulation in Peripheral Vestibular Dysfunction Patients
NA
Recruiting
50 participants
Started: Oct 25, 2021 · Completed: Jul 31, 2024
1 condition
1 sponsor
1 location
NCT05392387
Treatment and Prognosis of Patients With Chronic HBV Infection
N/A
Recruiting
500 participants
Started: Oct 25, 2021 · Completed: Oct 25, 2026
1 condition
1 sponsor
1 location
NCT04680260
OPTIMIzation of Treatment SElection and Follow up in Oligometastatic Colorectal Cancer
PHASE2
Recruiting
350 participants
Started: Oct 25, 2021 · Completed: Mar 1, 2030
2 conditions
3 sponsors
2 locations
NCT04337177
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
PHASE1
Recruiting
20 participants
Started: Oct 25, 2021 · Completed: Jun 30, 2026
6 conditions
1 sponsor
8 locations
NCT05132387
Wroclaw Out-Of-Hospital Cardiac Arrest Registry
N/A
Recruiting
50 participants
Started: Oct 25, 2021 · Completed: Jan 1, 2028
1 condition
2 sponsors
1 location
NCT05084625
PACED-digitized Support During Adjuvant Endocrine Therapy
NA
Recruiting
300 participants
Started: Oct 25, 2021 · Completed: Dec 31, 2024
4 conditions
8 sponsors
3 locations
NCT04975698
HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903
PHASE2
Active, not recruiting
12 participants
Started: Oct 25, 2021 · Completed: Jun 30, 2026
1 condition
6 sponsors
11 locations
NCT05025956
Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan
PHASE1/PHASE2
Active, not recruiting
68 participants
Started: Oct 24, 2021 · Completed: Oct 31, 2024
1 condition
2 sponsors
1 location
NCT05108948
Research of Factors Determining the Improvement of Quality of Life at One Year of Adult Patients Treated for Spinal Deformity (COFTASD)
N/A
Recruiting
866 participants
Started: Oct 23, 2021 · Completed: Oct 23, 2041
1 condition
2 sponsors
1 location
NCT06774781
Assessment of ADC Values and Radiomics Characteristics With a MRI of the Prostate to Identify Tumor Lesions
N/A
Recruiting
120 participants
Started: Oct 23, 2021 · Completed: Jan 31, 2025
1 condition
1 sponsor
1 location
NCT04969744
Impact of Cold Exposure on Metabolic Regulation in Children With Non Alcoholic Fatty Liver Disease (NAFLD)
NA
Recruiting
36 participants
Started: Oct 23, 2021 · Completed: Dec 31, 2024
1 condition
4 sponsors
1 location
NCT05023395
Safety and Efficacy of MEE-HU Medicus
PHASE2
Active, not recruiting
200 participants
Started: Oct 23, 2021 · Completed: May 11, 2024
1 condition
5 sponsors
2 locations
NCT04578652
Fiber and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance
PHASE3
Recruiting
90 participants
Started: Oct 22, 2021 · Completed: Sep 30, 2025
2 conditions
1 sponsor
1 location
NCT04921722
Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies
PHASE4
Recruiting
75 participants
Started: Oct 22, 2021 · Completed: Nov 1, 2025
4 conditions
1 sponsor
1 location
NCT04946916
Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease
NA
Recruiting
120 participants
Started: Oct 22, 2021 · Completed: Mar 22, 2028
4 conditions
1 sponsor
2 locations
NCT05108974
Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study
PHASE2
Active, not recruiting
62 participants
Started: Oct 22, 2021 · Completed: Jul 31, 2026
1 condition
2 sponsors
1 location
NCT04804891
Using T-Cell Alloreactivity and Chimerism to Guide Immunosuppression Minimization in Intestinal Transplantation
PHASE1
Recruiting
6 participants
Started: Oct 22, 2021 · Completed: Dec 31, 2028
1 condition
2 sponsors
1 location
NCT04975152
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
PHASE1
Active, not recruiting
36 participants
Started: Oct 22, 2021 · Completed: Mar 31, 2028
2 conditions
3 sponsors
1 location
NCT04234022
Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma
N/A
Recruiting
70 participants
Started: Oct 22, 2021 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04876053
Home Food Delivery for Diabetes Management in Patients of Rural Clinics
NA
Active, not recruiting
415 participants
Started: Oct 22, 2021 · Completed: Feb 6, 2026
2 conditions
1 sponsor
4 locations
NCT05174637
A Study of FDA018-ADC in Patients with Advanced Solid Tumors
PHASE1
Active, not recruiting
78 participants
Started: Oct 22, 2021 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT04677816
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients
PHASE2
Recruiting
50 participants
Started: Oct 22, 2021 · Completed: Mar 31, 2026
3 conditions
2 sponsors
1 location
NCT05229341
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
NA
Recruiting
1,450 participants
Started: Oct 22, 2021 · Completed: Oct 22, 2026
1 condition
2 sponsors
1 location
NCT04861259
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
PHASE3
Active, not recruiting
83 participants
Started: Oct 22, 2021 · Completed: Aug 20, 2029
1 condition
2 sponsors
45 locations
NCT04929223
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
PHASE1
Recruiting
542 participants
Started: Oct 22, 2021 · Completed: Nov 7, 2028
1 condition
1 sponsor
73 locations
NCT04815707
Treatment of Occult Inguinal Hernias
PHASE2
Active, not recruiting
252 participants
Started: Oct 22, 2021 · Completed: Oct 31, 2025
1 condition
2 sponsors
2 locations
NCT04864990
Dyspnea and Idiopathic Pulmonary Fibrosis
N/A
Recruiting
50 participants
Started: Oct 22, 2021 · Completed: Oct 31, 2025
1 condition
2 sponsors
1 location
NCT05055401
Airway Management Skills Amongst Anesthesia Providers
N/A
Enrolling by invitation
30 participants
Started: Oct 22, 2021 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT04987229
Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects
PHASE3
Enrolling by invitation
236 participants
Started: Oct 22, 2021 · Completed: Sep 30, 2027
2 conditions
1 sponsor
40 locations
NCT05132231
Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity
N/A
Active, not recruiting
394 participants
Started: Oct 22, 2021 · Completed: Mar 31, 2026
1 condition
1 sponsor
42 locations
NCT05091619
A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
PHASE3
Active, not recruiting
2,898 participants
Started: Oct 22, 2021 · Completed: Sep 22, 2027
3 conditions
2 sponsors
4 locations
NCT04921787
EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy
NA
Recruiting
24 participants
Started: Oct 22, 2021 · Completed: Apr 30, 2026
3 conditions
3 sponsors
4 locations
NCT04974593
Predictive Value of Hydrogen/methane Lactose Breath Testing on the Therapeutic Effect of Lactose-free Diet in Moderate to Severe ROME IV IBS.
PHASE3
Recruiting
90 participants
Started: Oct 22, 2021 · Completed: Jan 1, 2028
2 conditions
1 sponsor
1 location
NCT05167981
RETAINWORKS Impact Evaluation
NA
Recruiting
4,000 participants
Started: Oct 22, 2021 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT05050942
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients with GEP-NET
PHASE3
Active, not recruiting
332 participants
Started: Oct 22, 2021 · Completed: Dec 31, 2027
1 condition
1 sponsor
98 locations
NCT07178756
ACUPUNCTURE FOR THE POSTOPERATIVE RECOVERY OF HIP FRACTURE PATIENTS: A PILOT RANDOMIZED CONTROLLED TRIAL
NA
Active, not recruiting
90 participants
Started: Oct 21, 2021 · Completed: Nov 14, 2025
2 conditions
2 sponsors
2 locations
NCT05056077
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
NA
Recruiting
1,000 participants
Started: Oct 21, 2021 · Completed: Dec 31, 2027
9 conditions
6 sponsors
1 location
NCT05176665
EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
PHASE1/PHASE2
Recruiting
152 participants
Started: Oct 21, 2021 · Completed: Dec 31, 2025
3 conditions
2 sponsors
14 locations
NCT05177562
Reproductive Endocrinology Oxford Study (RepOx)
N/A
Recruiting
1,175 participants
Started: Oct 21, 2021 · Completed: Sep 1, 2028
1 condition
3 sponsors
1 location
NCT04997941
Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer Patients
PHASE2
Active, not recruiting
238 participants
Started: Oct 21, 2021 · Completed: Dec 31, 2028
2 conditions
1 sponsor
1 location
NCT04974008
Osteosarcoma Maintenance Therapy With OST31-164
PHASE2
Active, not recruiting
39 participants
Started: Oct 21, 2021 · Completed: Oct 31, 2027
1 condition
1 sponsor
21 locations
NCT05435495
Mechanisms of Resistance to PSMA Radioligand Therapy
N/A
Recruiting
125 participants
Started: Oct 21, 2021 · Completed: Dec 31, 2025
1 condition
3 sponsors
3 locations
NCT04652960
Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome
PHASE1
Active, not recruiting
38 participants
Started: Oct 21, 2021 · Completed: Nov 3, 2027
3 conditions
1 sponsor
17 locations
NCT04708054
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
PHASE2/PHASE3
Recruiting
324 participants
Started: Oct 21, 2021 · Completed: Dec 31, 2027
3 conditions
1 sponsor
1 location
NCT06940349
Interventional Study to Evaluate the Combination of Palbociclib + Sunitinib as a Treatment for Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
100 participants
Started: Oct 21, 2021 · Completed: Jan 1, 2028
1 condition
1 sponsor
1 location
NCT04857372
A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
PHASE1
Active, not recruiting
137 participants
Started: Oct 21, 2021 · Completed: Sep 4, 2026
1 condition
1 sponsor
16 locations
NCT05068310
Applicability of a Cellular Resolution Full-field OCT Image System for Pigmented and Non-pigmented Skin Tumors
N/A
Recruiting
200 participants
Started: Oct 21, 2021 · Completed: Feb 28, 2025
2 conditions
1 sponsor
1 location
NCT04617678
A Comprehensive Approach to Head and Neck Cancer Prehabilitation
NA
Enrolling by invitation
80 participants
Started: Oct 21, 2021 · Completed: Dec 31, 2026
1 condition
2 sponsors
2 locations
NCT05422430
Rebreathing-induced Hypoxia and Glucose Levels
NA
Active, not recruiting
20 participants
Started: Oct 21, 2021 · Completed: Apr 30, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
1853
1854
1855
1856
1857
1858
1859
More pages
2369
Next